Overcoming Barriers to Equitable Care in Hepatocellular Carcinoma: Integrating New Evidence Into Clinical Practice

Target Audience
This activity is designed specifically for oncologists, advanced practice providers, and other members of the healthcare team who serve patients from rural and underserved communities.

Program Overview
In rural and underserved communities, the incidence of hepatocellular carcinoma (HCC) continues to rise steadily, especially among Blacks and non-Hispanic Whites. Unique challenges in these areas such as oncology workforce shortages and transportation barriers exacerbate the problem, making residents more likely to be diagnosed with HCC at a late stage and less likely to receive treatment compared with those in urban areas. In this activity, expert faculty will review current and emerging treatment options and strategies for individualizing therapy for patients with unresectable disease. Evidence-based methods to reduce disparities and improve access to HCC care in rural and underserved settings will also be discussed.

This enduring activity is a recorded session from Oncology Congress that took place on September 24, 2022.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Apply clinical evidence on the efficacy and safety of systemic therapies for unresectable hepatocellular carcinoma (HCC) into clinical practice
Develop personalized treatment plans that consider individual patient and disease characteristics as well as clinical profiles of therapeutic options for unresectable HCC
Implement evidence-based strategies for reducing disparities in HCC care access and treatment in rural and underserved settings